Prescription Gabapentin Capsules Recalled for Defective Blister Packaging
The Harvard Drug Group LLC is recalling Gabapentin Capsules due to inadequately sealed blister packaging. Patients should contact their pharmacy or healthcare provider regarding affected lots M05205A and M05205B.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or hospitalizations. The defect is a packaging integrity issue with no documented patient harm, fitting the Moderate category for precautionary pharmaceutical recalls.
Plain-English summary
The Harvard Drug Group LLC is recalling Gabapentin Capsules, USP, 100 mg due to defective containers with inadequately sealed blister packaging.
The recall includes 3,527 bags with lot numbers M05205A and M05205B, expiring October 2026. The affected product was packaged and distributed by Major Pharmaceuticals, Indianapolis, Indiana, and distributed by Cardinal Health. Distribution was nationwide.
Patients taking this recalled medication should contact their pharmacy or healthcare provider. Do not use the recalled product. Return unused medication to the pharmacy for proper disposal.
The recalled product
- Product
- GABAPENTIN (GABAPENTIN)
- Brand
- GABAPENTIN
- Manufacturer
- The Harvard Drug Group LLC
- Category
- Drug
- Hazard
- packaging-defect
- seal-integrity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# M05205A and M05205B
- Exp Date 10/2026.
UPCs (2)
- 0055154336307
- 0055154799201
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GABAPENTIN
- HighGabapentin Capsules Nationwide Recall for Failed Impurity Specifications
FDA (Drugs) · 2025-10-29
- ModerateGabapentin Prescription Capsules Recalled for Failed Impurity Specifications
FDA (Drugs) · 2025-10-29
- HighGabapentin capsules recalled due to inadequately sealed blister packaging
FDA (Drugs) · 2025-07-09
- ModeratePrescription Gabapentin 300 mg Capsules Recalled for Cross Contamination
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Gabapentin 600mg tablets recalled for manufacturing deviations
FDA (Drugs) · 2025-04-16
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27